ArticleCell reports. Medicine2024

CD97 maintains tumorigenicity of glioblastoma stem cells via mTORC2 signaling and is targeted by CAR Th9 cells.

Shuchang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.